TETRAPHASE PHARMACEUTICALS INC: cashflow_financing

Value{"amount": -837000, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Period2012-01-01 – 2012-06-30
Statuscurrent
EntityTETRAPHASE PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001193125-13-331037 · Open the official SEC filing →
Retrieved: 2026-08-19T13:11:17.864451+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001373707/cashflow-financing/2012-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/c05a8bd5-6bdd-4722-b9b9-73eb7d7a8bba

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies